What is ClearFlow?
ClearFlow operates at the intersection of surgical innovation and patient-centric care, focusing on the development of advanced medical technologies designed to mitigate complications in cardiac procedures. The company's core portfolio, which includes the PleuraFlow Active Clearance Technology and the ClearFix Rigid Sternal Fixation system, is engineered to reduce the incidence of Retained Blood Syndrome and improve overall recovery metrics. By targeting high-acuity healthcare institutions, ClearFlow provides essential tools that not only enhance clinical outcomes but also optimize resource utilization within hospital settings. Their commitment to advancing surgical standards is further supported by a robust educational framework for medical professionals, ensuring the effective integration of their proprietary solutions into standard cardiac care protocols.
How much funding has ClearFlow raised?
ClearFlow has raised a total of $21.8M across 8 funding rounds:
Private Equity
$1.2M
Private Equity
$4.9M
Private Equity
$4.2M
Debt
$2.8M
Private Equity
$5.5M
Debt
$350K
Debt
$2.1M
Private Equity (2010): $1.2M, investors not publicly disclosed
Private Equity (2011): $4.9M, investors not publicly disclosed
Private Equity (2013): $4.2M, investors not publicly disclosed
Debt (2014): $2.8M, investors not publicly disclosed
Private Equity (2015): $5.5M, investors not publicly disclosed
Debt (2020): $350K led by PPP
Debt (2025): $2.1M, investors not publicly disclosed
Key Investors in ClearFlow
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for ClearFlow?
With the successful acquisition of $2.1M, ClearFlow is well-positioned to accelerate its enterprise-level growth strategy. The company is expected to leverage this capital to deepen its market penetration, potentially expanding its product pipeline to address broader cardiovascular surgical needs. As the firm transitions into this next phase of development, the focus will likely shift toward scaling manufacturing capabilities and broadening its reach within international healthcare markets. By maintaining a rigorous commitment to clinical efficacy and surgical precision, ClearFlow aims to establish its technologies as the standard of care for cardiac recovery, ultimately driving long-term value for both clinical stakeholders and institutional partners.
See full ClearFlow company page
